Show and Tell today, Friends!
I received my demo kit of the Solo tubeless insulin pumping system the other day. That’s the would-be competitor to OmniPod which was acquired by Roche Diabetes last month. It’s not yet on the market — in fact, not slated to be available until 2012, but you can order a free sample “pod” to give the thing a try if you’re very curious. I was.
Too bad you can’t get a…
Read more »
By
AmyT on
April 19, 2010
Thankfully, many readers send me emails when they hear about something newsworthy/ different/ fun/ controversial/ or quirky in the world of diabetes. Thank you! And keep those tips coming, pahhhleeese, People.
Today, from the mailbag, three items that I simply had to share:
New OneTouch Delica Lancing Device
This one’s so new it doesn’t even appear on the JNJ OneTouch website yet — but appears to available via DiabeticPromotions.
According to my reader tip: “At first…
Read more »
By
AmyT on
April 14, 2010
I’m sure many of you heard the news yesterday that Roche Diabetes has acquired Israel-based Medingo, makers of the much-anticipated Solo insulin patch pump — a would-be direct competitor to the OmniPod tubeless pumping system.
Roche paid $160 million for the small company and its technology, which is a drop in the bucket in industry terms. The press release predicts “worldwide availability by 2012.”
In case you’re wondering, the Solo system already had an integrated…
Read more »
By
AmyT on
March 30, 2010
I just knew that working with expert CDE Gary Scheiner was going to be eye-opening. After all, I’ve barely touched the settings on my pump since I started using it three years ago. What a sense of empowerment to start altering so many Pump Settings — which have frankly intimidated the heck out of me until now.
Based on those yucky basal testing exercises, we have completely revamped my basal settings, with no less than seven…
Read more »
By
AmyT on
March 17, 2010
Happy St. Patrick’s Day, again. See this morning’s post with some wee silliness on that.
A quick newsflash on this lovely green day: this morning Medtronic has announced that it has received FDA approval for its new Paradigm Revel combination insulin pump/continuous glucose monitor, which they’re calling “the industry’s most advanced integrated system for diabetes management” (see product info here).
That may be an overstatement, considering the Revel does not include the automatic-suspend feature that…
Read more »